Lugtenburg EJ, Brown P, van der Holt B, et al. Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study. ASCO Annual Meeting 2019, abstract 7507.
Veelbelovende nieuwe immuuntherapie tegen kanker
okt 2024 | Immuuntherapie, Lymfoom